Local Institution - 0232 — Pittsburgh, Pennsylvania

Local Institution - 0232 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0232 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma (RRMM).

Sponsors: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0232?

Local Institution - 0232 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0232 conducted?

Local Institution - 0232 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory Multiple Myeloma (RRMM).

Is Local Institution - 0232 accredited by Crixeo Clinical Trials?

Local Institution - 0232 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0232?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.